OnKure Therapeutics, Inc. — SC 13D Filings
5 SC 13D filings on record
This page lists all SC 13D filings submitted to the SEC by OnKure Therapeutics, Inc. (OKUR), sorted by most recent first. Each row links to the full filing on EdgarLookup. OnKure Therapeutics, Inc. has filed 5 SC 13D documents with the SEC since 2018. To view all SEC filings by OnKure Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D | — | 0001214659-23-016861 | Dec 26, 2023 | — |
| SC 13D | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D | 0001072613-21-000379 | Apr 23, 2021 | — |
| SC 13D | SC 13D | 0000905718-21-000606 | Apr 20, 2021 | — |
| SC 13D | SC 13D | 0001193125-21-120962 | Apr 19, 2021 | — |
| SC 13D | SC 13D | 0001193125-21-116375 | Apr 14, 2021 | — |